Yonglun Luo Department of Biomedicine, Aarhus University, Denmark
1 protocol

GuangQian Zhou 0 protocol

CuiPing Mo 0 protocol

ChongZhou Fang Lungene Technologies Co., Ltd, China, China,
0 protocol

Yan Zhou
  • Lungene Technologies Co., Ltd, China, China,
  • 1 Author merit


PhD, Aarhus University, Denmark, 2017

Current position

Technical director, Lungene Technologies Co., Ltd, Lungene Technologies Co., Ltd, China


  1. Kai Xiong*, Yan Zhou*, Kristian Aabo Blichfeld*, Poul Hyttel et al., RNA-Guided Activation of Pluripotency Genes in Human Fibroblasts. Cellular Reprogramming 2017, 19(3):189-198 
  2. Yan Zhou*, Rasha Abdelkadhem Al-Saaidi*, Paula Fernandez Guerra, Kristine K. Freude, Rikke Katrine Jentoft Olsen et al., Mitochondrial Spare Respiratory Capacity Is Negatively Correlated With Nuclear Reprogramming Efficiency. Stem Cells and Development 2017, 26(3):166-176
  3. Kai Xiong*, Yan Zhou*, Poul Hyttel, Lars Bolund, Kristine Karla Freude, and Yonglun Luo, Generation of Induced pluripotent stem cells (iPSCs) stably expressing CRISPR-based synergistic activation mediator (SAM). Stem Cell Research 2016, 17(3):665-669 
  4. Yan Zhou*, Yong Liu*, Dianna Hussmann*, Peter Brøgger*, Rasha Abdelkadhem Al-Saaidi et al., Enhanced genome editing in mammalian cells with a modified dual-fluorescent surrogate system. Cellular and molecular life sciences 2016, 73(13):2543-2563 
  5. Ran Kang*, Yan Zhou*, Shuang Tan, Guangqian Zhou, Lars Aagaard et al., Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity. Stem cell research & therapy 2015, 6:144